IRCT2017022532769N1已完成未知
The evaluation of sitagliptin on proteinuria in diabetic patient with nephropathy.
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 49
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •Type 2 of diabet ; glomerular filtration rate more than 30 ; HbA1C 6.5-8.5 ; continue of previous diet , exersize & drug ; proteinuria more than 150mg/dl.
- •Exclusion criteria: Patient do not allow continue of study ; drug adverse reaction ; blood suger more than difined range ; exacerbation of renal failure.
排除标准
- 未提供
研究者
相似试验
已完成
3 期
Effect of sitagliptine on proteinuriaDiabetic nephropathy.Type 2 diabetes mellitus with diabetic nephropathyE11.21IRCT20201028049174N1Esfahan University of Medical Sciences90
已完成
不适用
The effects of sitagliptin on albuminuria in patients with type 2 diabetes mellitustype 2 diabetes mellitusJPRN-UMIN000010871niversity of Occupational and Environmental Health100
已完成
不适用
Study on usefulness of sitagliptin in patients with type 2 diabetesJPRN-UMIN000007477Department of Applied Molecular Medicine, Niigata University Graduate School of Medical and Dental Sciences200
招募中
3 期
Effect of Linagliptin on diabetic proteinuriaIRCT20090905002417N23Esfahan University of Medical Sciences140
已完成
1 期
Effects of sitagliptin, a dipeptidyl peptidase IV (DPP IV) inhibitor, on blood glucose and plasma incretin and insulin responses to small intestinal glucose infusion, in healthy lean and obese subjects, and alone or in combination with metformin in patients with type 2 diabetes mellitus.ACTRN12608000433303Royal Adelaide Hospital36